OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA (CML) IN THE EARLY IMATINIB MESYLATE (IM) ERA

被引：0
|
作者：
Khoury, H. J. [1 ]
Kukreja, M. [1 ]
Wang, T. [1 ]
Woolfrey, A. [1 ]
Szer, J. [1 ]
Cortes, J. [1 ]
Horowitz, M. M. [1 ]
Lee, S. [1 ]
机构：
[1] CIBMTR, Milwaukee, WI USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
151
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [31] Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
    Hu, Bei
    Lin, Xiao
    Lee, Hans C.
    Huang, Xuelin
    Tidwell, Rebecca S. Slack
    Ahn, Kwang Woo
    Hu, Zhen-Huan
    Jabbour, Elias
    Verstovsek, Srdan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Kharfan-Dabaja, Mohamed A.
    Hossain, Nasheed M.
    Marks, David I.
    Kamble, Rammuriti T.
    Inamoto, Yoshihiro
    Kindwall-Keller, Tamila
    Saad, Ayman
    Litzow, Mark R.
    Savani, Bipin N.
    Hale, Gregory A.
    Bacher, Ulrike
    Gerds, Aaron T.
    Liesveld, Jane L.
    Ustun, Celalettin
    Olsson, Richard F.
    Daly, Andrew
    Grunwald, Michael R.
    Solh, Melhem
    DeFilipp, Zachariah
    Aljurf, Mahmoud
    Wirk, Baldeep
    Akpek, Gorgun
    Nishihori, Taiga
    Cerny, Jan
    Seo, Sachiko
    Hsu, Jack W.
    Champlin, Richard
    de Lima, Marcos
    Alyea, Edwin
    Popat, Uday
    Sobecks, Ronald
    Scott, Bart L.
    Kantarjian, Hagop
    Cortes, Jorge
    Saber, Wael
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2811 - 2820
  • [32] Imatinib mesylate in the treatment of relapse of chronic myeloid leukemia after allogeneic stem sell transplantation.
    Zhu, KG
    Zhang, T
    Chen, J
    Zhong, J
    BLOOD, 2005, 106 (11) : 291B - 291B
  • [33] Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
    Saussele, Susanne
    Lauseker, Michael
    Gratwohl, Alois
    Beelen, Dietrich W.
    Bunjes, Donald
    Schwerdtfeger, Rainer
    Kolb, Hans-Jochem
    Ho, Anthony D.
    Falge, Christiane
    Holler, Ernst
    Schlimok, Guenter
    Zander, Axel R.
    Arnold, Renate
    Kanz, Lothar
    Dengler, Robert
    Haferlach, Claudia
    Schlegelberger, Brigitte
    Pfirrmann, Markus
    Mueller, Martin C.
    Schnittger, Susanne
    Leitner, Armin
    Pletsch, Nadine
    Hochhaus, Andreas
    Hasford, Joerg
    Hehlmann, Ruediger
    BLOOD, 2010, 115 (10) : 1880 - 1885
  • [34] Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era
    Doherty, Erin E.
    Redell, Michele
    Sasa, Ghadir
    Yassine, Khaled
    John, Tami D.
    Craddock, John
    Wu, Mengfen
    Wang, Tao
    Martinez, Caridad A.
    Krance, Robert A.
    Naik, Swati
    BLOOD, 2019, 134
  • [35] Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era
    Doherty, Erin E.
    Redell, Michele
    Sasa, Ghadir
    Yassine, Khaled
    John, Tami
    Craddock, John
    Martinez, Caridad
    Krance, Robert A.
    Naik, Swati
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S100 - S100
  • [36] Effective treatment with imatinib mesylate and donor lymphocyte infusion following relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Li, JY
    Wu, HX
    Qian, SX
    Hong, M
    Xiao, B
    Zhang, R
    Ruan, CG
    BLOOD, 2005, 106 (11) : 441B - 441B
  • [37] Challenges for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
    Oyekunle, Anthony
    Klyuchnikov, Evgeny
    Ocheni, Sunday
    Kroeger, Nicolaus
    Zander, Axel R.
    Baccarani, Michele
    Bacher, Ulrike
    ACTA HAEMATOLOGICA, 2011, 126 (01) : 30 - 39
  • [38] Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    XU Lan-ping
    HUANG Xiao-jun
    中华医学杂志（英文版）, 2013, 126 (04) : 768 - 774
  • [39] Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Xu Lan-ping
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 768 - 774
  • [40] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)
    Lipof, Jodi J.
    Manogna, Dharmini
    Baran, Andrea M.
    Said, Bassil
    Becker, Michael W.
    Mendler, Jason H.
    Aljitawi, Omar S.
    O'Dwyer, Kristen Marie
    Huselton, Eric
    Burack, Richard
    Blaney, Margaret
    Douglas, Taylor
    Liesveld, Jane L.
    Loh, Kah Poh
    BLOOD, 2020, 136
12345